NGEN-Enzy LP — Form D/A
NGEN-Enzy LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2024-09-03. $21.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-09-03
- Form: D/A
- Accession: 0002005822-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $21.6M
- Investors: 7
- Date of first sale: 2024-01-04
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-500867
Issuer
- Name: NGEN-Enzy LP
- CIK: 0002005822
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: C/O NGEN ENZYMEDICA LLC, NEW YORK, NY, 10021
- Phone: 212.450.9704
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| N/A NGEN Enzymedica LLC | Director | New York, NY |
| Peter Grubstein | Executive Officer | New York, NY |
| Shay Murphy | Executive Officer | New York, NY |
| Rosemary Ripley | Executive Officer | New York, NY |
Other filings by this issuer (1)
More